Stay updated on Aptose Biosciences Press Releases

Sign up to get notified when there's something new on the Aptose Biosciences Press Releases page.
Latest website image capture
Clouds background image

Latest updates to the Aptose Biosciences Press Releases page

  1. Check
    3 days ago
    No Change Detected
  2. Check
    10 days ago
    No Change Detected
  3. Check
    17 days ago
    Change Detected
    Summary
    Added a new press release dated Feb 24, 2026: Aptose Biosciences Announces Amendment to Arrangement Agreement and Details of Postponed Special Meeting of Shareholders. Deleted the Aug 13, 2025 entry: Aptose Reports Second Quarter 2025 Results.
    Difference
    2%
    Check dated 2026-02-27T16:20:12.000Z thumbnail image
  4. Check
    68 days ago
    Change Detected
    Summary
    Footer copyright year updated from 2025 to 2026 on the Press Releases page. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2026-01-08T01:57:03.000Z thumbnail image
  5. Check
    82 days ago
    Change Detected
    Summary
    Added a new press release about rescheduling the shareholder meeting to approve the acquisition by Hanmi pending SEC clearance. Removed an older press release announcing enrollment for the 160 mg dosing cohort of the Tuspetinib Phase 1/2 TUSCANY trial.
    Difference
    2%
    Check dated 2025-12-24T15:32:40.000Z thumbnail image
  6. Check
    97 days ago
    Change Detected
    Summary
    Added a new press release entry dated Dec 06, 2025 announcing Aptose’s Tuspetinib triple-drug therapy featured at the 2025 ASH Annual Meeting. Removed the Aug 01, 2025 notice about selecting Ernst & Young as auditor and the reconvened shareholders meeting.
    Difference
    2%
    Check dated 2025-12-10T03:46:16.000Z thumbnail image
  7. Check
    111 days ago
    Change Detected
    Summary
    Added the press release: Aptose Biosciences Announces Arrangement Agreement for Acquisition by Hanmi Pharmaceutical (Nov 19, 2025). Deleted the July 15, 2025 press release titled Aptose Receives Second Advance under the Loan Agreement with Hanmi Pharmaceutical to Continue Development of Tuspetinib in Triplet Therapy for AML.
    Difference
    2%
    Check dated 2025-11-25T22:16:29.000Z thumbnail image
  8. Check
    118 days ago
    Change Detected
    Summary
    New entries have been added to the press releases list, including Aptose Reports Third Quarter 2025 Results on Nov 13, 2025. An older release about Aptose Upgraded to Trade on OTCQB Market was removed, updating the current archive.
    Difference
    2%
    Check dated 2025-11-18T20:56:25.000Z thumbnail image

Stay in the know with updates to Aptose Biosciences Press Releases

Enter your email address, and we'll notify you when there's something new on the Aptose Biosciences Press Releases page.